Substitutions, deletions and duplications in the dystrophin gene lead to either the severe Duchenne muscular dystrophy (DMD) or mild Becker muscular dystrophy depending on whether out-of-frame or in-frame transcripts are produced. We identified a DMD case (GSΔ44) where the correlation between genotype and phenotype is not respected, even if carrying a typical Duchenne mutation (exon 44 deletion) a Becker-like phenotype was observed. Here we report that in this patient, partial restoration of an in-frame transcript occurs by natural skipping of exon 45 and that this is due to the lack of Celf2a, a splicing factor that interacts with exon 45 in the dystrophin pre-mRNA. Several experiments are presented that demonstrate the central role of Celf2a in controlling exon 45 splicing; our data point to this factor as a potential target for the improvement of those DMD therapeutic treatments, which requires exon 45 skipping.
The lack of the Celf2a splicing factor converts a Duchenne genotype into a Becker phenotype / Martone, Julie; Briganti, F; Legnini, Ivano; Morlando, Mariangela; Picillo, E; Sthandier, Olga Elena; Politano, L; Bozzoni, Irene. - In: NATURE COMMUNICATIONS. - ISSN 2041-1723. - STAMPA. - 7:(2016), pp. 1-8. [10.1038/ncomms10488]
The lack of the Celf2a splicing factor converts a Duchenne genotype into a Becker phenotype
MARTONE, Julie;Briganti, F;LEGNINI, IVANO;MORLANDO, MARIANGELA;STHANDIER, Olga Elena;BOZZONI, Irene
2016
Abstract
Substitutions, deletions and duplications in the dystrophin gene lead to either the severe Duchenne muscular dystrophy (DMD) or mild Becker muscular dystrophy depending on whether out-of-frame or in-frame transcripts are produced. We identified a DMD case (GSΔ44) where the correlation between genotype and phenotype is not respected, even if carrying a typical Duchenne mutation (exon 44 deletion) a Becker-like phenotype was observed. Here we report that in this patient, partial restoration of an in-frame transcript occurs by natural skipping of exon 45 and that this is due to the lack of Celf2a, a splicing factor that interacts with exon 45 in the dystrophin pre-mRNA. Several experiments are presented that demonstrate the central role of Celf2a in controlling exon 45 splicing; our data point to this factor as a potential target for the improvement of those DMD therapeutic treatments, which requires exon 45 skipping.File | Dimensione | Formato | |
---|---|---|---|
Martone_Lack_2016.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
620.15 kB
Formato
Adobe PDF
|
620.15 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.